HMGB1 and breast fibrocystic disease: They found that the levels of HMGB1 in breast tissues and serum were significantly higher in breast cancer patients than in patients with benign breast disease or the normal population, suggesting that serum HMGB1 may be a useful serological biomarker for the diagnosis of breast cancer 2.